Evidence map›Paper›PMID 38633621›Full record

ArticleOpen respiratory archives

[National Survey on the Activity of Lung Function Laboratories. Effects During the SARS-COV-2 Pandemic].

Laura Vigil Giménez, Juana Martínez Llorens, Karina Portillo Carroz, Rocío García García, Francisco Ortega Ruiz, Luis Puente Maestu, en representación del Grupo de Trabajo

Open access · goldAbstract readEnglish Abstract
In one paragraph

Article in Open respiratory archives. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Laura Vigil GiménezServicio de Neumología, Parc Taulí Hospital Universitari, Insitut d' Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Barcelona, España.
Juana Martínez LlorensServicio de Neumología, Hospital del Mar, Barcelona, CEXS, Universitat Pompeu Fabra, Barcelona, CIBER de Enfermedades Respiratorias (CIBERES), ISC III, Madrid, España.
Karina Portillo CarrozServicio de Neumología, Hospital Germans Tries i Pujol, Badalona, Barcelona, España.
Rocío García GarcíaServicio de Neumología, Hospital Universitario 12 de Octubre, Madrid, España.
Francisco Ortega RuizServicio de Neumología, Hospital Virgen del Rocío, Sevilla, España.
Luis Puente MaestuServicio de Neumología, Hospital Universitario Gregorio Marañón, Madrid, España.
en representación del Grupo de Trabajo
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESHospital General Universitario Gregorio Marañón · ESHospital Universitari Germans Trias i Pujol · ESHospital Universitario 12 De Octubre · ESHospital Universitario Virgen del Rocío · ESUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Following the SARS-CoV-2 pandemic in March 2020, pulmonary function testing (PFT) laboratories underwent a transformation, with a reduction in the number of tests or closure in some cases. The aim of this work was to know the activity of PFT in Spain and the modification of this activity due to the pandemic. Material and methods: A protocolised survey was carried out to members of the PFT laboratories through the Spanish Society of Pneumology and Thoracic Surgery (SEPAR). Results: Thirty-nine hospitals in Spain responded. The pulmonary function tests most frequently performed in the PFT laboratories were forced spirometry with bronchodilator test (100%), body plethysmography (97.4%), CO transfer capacity (97.4%), respiratory muscle strength measured in the mouth (97.4%), 6-minute walking test (94.7%), measurement of exhaled fraction of nitric oxide (92.3%) and incremental exercise test (71.8%).The pandemic led to a significant decrease in the number of tests (35.4%) during 2020 with subsequent recovery in 2021, without reaching pre-pandemic values.The most important changes were increased examination times, working with personal protective equipment and ventilation of the rooms. The performance of the nasopharyngeal swab for SARS-CoV2 testing prior to the tests was not homogeneous in the PFT laboratories. Conclusions: Most hospitals are sufficiently equipped to perform the most common pulmonary function tests. The pandemic resulted in a loss of activity in all hospitals.

Indexed as

Cardiopulmonary exercise testCOVIDPandemicPulmonary function testing laboratorySARS-CoV-2 virusSpirometry

Identifiers

PMID38633621
PMCPMC11021358
OpenAlexW4392881899

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.